GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NeuroScientific Biopharmaceuticals NSB.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.05

+3.85%

Close of 27 Oct 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

NeuroScientific Biopharmaceuticals — daily ASX:NSB

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View NeuroScientific Biopharmaceuticals on TradingView ↗
Market value
A$18.0m
Last close × shares
Volume
209.5k
Shares, 27 Oct 2026

About NeuroScientific Biopharmaceuticals

Its shares trade on ASX under the ticker NSB.AX. It has been listed since 27 July 2018. In the fiscal year to 30 June 2025, it reported revenue of A$166,100 and a net loss of A$1.8m. At that date it held total assets of A$17.0m and shareholders' equity of A$16.8m.

Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. The Company’s product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body’s innate immune response to cell injury.

Figures and description from our data supplier, not checked against the company's own report.

More about NeuroScientific Biopharmaceuticals →

Latest on NeuroScientific Biopharmaceuticals

Our reporting

We have not reported on NeuroScientific Biopharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is NeuroScientific Biopharmaceuticals's ticker?

NeuroScientific Biopharmaceuticals trades as NSB.AX on ASX, under ISIN AU0000012973.

What was NeuroScientific Biopharmaceuticals's last closing price?

0.05 on 27 Oct 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.